CN111867599A - 放射敏感性组织中细胞保护剂的选择性积聚及其用途 - Google Patents

放射敏感性组织中细胞保护剂的选择性积聚及其用途 Download PDF

Info

Publication number
CN111867599A
CN111867599A CN201880082136.8A CN201880082136A CN111867599A CN 111867599 A CN111867599 A CN 111867599A CN 201880082136 A CN201880082136 A CN 201880082136A CN 111867599 A CN111867599 A CN 111867599A
Authority
CN
China
Prior art keywords
radiation
tissue
organ
dose
cytoprotective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880082136.8A
Other languages
English (en)
Chinese (zh)
Inventor
詹姆斯·图尔
卡伦·泰尼古奇
凯西·马松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William Marsh Rice University
University of Texas System
Leland Stanford Junior University
Original Assignee
William Marsh Rice University
University of Texas System
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Marsh Rice University, University of Texas System, Leland Stanford Junior University filed Critical William Marsh Rice University
Publication of CN111867599A publication Critical patent/CN111867599A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1094—Shielding, protecting against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201880082136.8A 2017-11-21 2018-11-19 放射敏感性组织中细胞保护剂的选择性积聚及其用途 Pending CN111867599A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762589155P 2017-11-21 2017-11-21
US62/589,155 2017-11-21
PCT/US2018/061888 WO2019103983A1 (en) 2017-11-21 2018-11-19 Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof

Publications (1)

Publication Number Publication Date
CN111867599A true CN111867599A (zh) 2020-10-30

Family

ID=66631627

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880082136.8A Pending CN111867599A (zh) 2017-11-21 2018-11-19 放射敏感性组织中细胞保护剂的选择性积聚及其用途

Country Status (8)

Country Link
US (1) US11478489B2 (https=)
EP (1) EP3713534A4 (https=)
JP (2) JP2021510380A (https=)
KR (1) KR20200121286A (https=)
CN (1) CN111867599A (https=)
AU (2) AU2018372917A1 (https=)
CA (1) CA3083238C (https=)
WO (1) WO2019103983A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9855445B2 (en) 2016-04-01 2018-01-02 Varian Medical Systems, Inc. Radiation therapy systems and methods for delivering doses to a target volume
US10092774B1 (en) 2017-07-21 2018-10-09 Varian Medical Systems International, AG Dose aspects of radiation therapy planning and treatment
US11712579B2 (en) 2017-07-21 2023-08-01 Varian Medical Systems, Inc. Range compensators for radiation therapy
US11590364B2 (en) 2017-07-21 2023-02-28 Varian Medical Systems International Ag Material inserts for radiation therapy
US10549117B2 (en) 2017-07-21 2020-02-04 Varian Medical Systems, Inc Geometric aspects of radiation therapy planning and treatment
US10843011B2 (en) 2017-07-21 2020-11-24 Varian Medical Systems, Inc. Particle beam gun control systems and methods
US10183179B1 (en) 2017-07-21 2019-01-22 Varian Medical Systems, Inc. Triggered treatment systems and methods
EP3654976A1 (en) 2017-07-21 2020-05-27 Varian Medical Systems, Inc. Methods of use of ultra-high dose rate radiation and therapeutic agents
US11007381B2 (en) 2017-11-16 2021-05-18 Varian Medical Systems, Inc Increased beam output and dynamic field shaping for radiotherapy system
US10910188B2 (en) 2018-07-25 2021-02-02 Varian Medical Systems, Inc. Radiation anode target systems and methods
US10814144B2 (en) 2019-03-06 2020-10-27 Varian Medical Systems, Inc. Radiation treatment based on dose rate
US11116995B2 (en) 2019-03-06 2021-09-14 Varian Medical Systems, Inc. Radiation treatment planning based on dose rate
US11103727B2 (en) 2019-03-08 2021-08-31 Varian Medical Systems International Ag Model based PBS optimization for flash therapy treatment planning and oncology information system
US11090508B2 (en) 2019-03-08 2021-08-17 Varian Medical Systems Particle Therapy Gmbh & Co. Kg System and method for biological treatment planning and decision support
US10918886B2 (en) 2019-06-10 2021-02-16 Varian Medical Systems, Inc. Flash therapy treatment planning and oncology information system having dose rate prescription and dose rate mapping
US11291859B2 (en) 2019-10-03 2022-04-05 Varian Medical Systems, Inc. Radiation treatment planning for delivering high dose rates to spots in a target
US12390662B2 (en) 2020-04-02 2025-08-19 Siemens Healthineers International Ag System and method for proton therapy treatment planning with proton energy and spot optimization
US11865361B2 (en) 2020-04-03 2024-01-09 Varian Medical Systems, Inc. System and method for scanning pattern optimization for flash therapy treatment planning
US11541252B2 (en) 2020-06-23 2023-01-03 Varian Medical Systems, Inc. Defining dose rate for pencil beam scanning
US11957934B2 (en) 2020-07-01 2024-04-16 Siemens Healthineers International Ag Methods and systems using modeling of crystalline materials for spot placement for radiation therapy
US12064645B2 (en) 2020-07-02 2024-08-20 Siemens Healthineers International Ag Methods and systems used for planning radiation treatment
CN113768940A (zh) * 2021-08-25 2021-12-10 中国辐射防护研究院 一种放射性肺损伤的防护方法
WO2025075691A1 (en) * 2023-10-07 2025-04-10 Xerient Pharma Ltd. Irradiation protection methods uses and compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210694A (zh) * 2011-04-12 2011-10-12 上海长征医院 一种氨磷汀口服制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573253B2 (en) * 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6239119B1 (en) * 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
WO2007047315A1 (en) 2005-10-20 2007-04-26 Albemarle Corporation Amifostine dihydrate crystalline composition
US9393439B2 (en) 2010-03-01 2016-07-19 Intraop Medical Corporation Radiotherapy combined with hypoxic cell sensitizers
US9408882B2 (en) 2011-03-18 2016-08-09 Albert Einstein College Of Medicine, Inc. Oral administration of melanin for protection against radiation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210694A (zh) * 2011-04-12 2011-10-12 上海长征医院 一种氨磷汀口服制剂及其制备方法

Also Published As

Publication number Publication date
JP2021510380A (ja) 2021-04-22
AU2024227095A1 (en) 2024-10-24
WO2019103983A1 (en) 2019-05-31
CA3083238A1 (en) 2019-05-31
EP3713534A1 (en) 2020-09-30
EP3713534A4 (en) 2021-08-25
AU2018372917A1 (en) 2020-06-18
JP2024026262A (ja) 2024-02-28
KR20200121286A (ko) 2020-10-23
US11478489B2 (en) 2022-10-25
US20200360406A1 (en) 2020-11-19
CA3083238C (en) 2024-02-13

Similar Documents

Publication Publication Date Title
US11478489B2 (en) Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof
US10238630B2 (en) Use of eribulin and poly (ADP ribose) polymerase (PARP) inhibitors as combination therapy for the treatment of cancer
ES3015717T3 (en) A lysyl oxidase-like 2 inhibitor for use in treating myelofibrosis
CN105338977A (zh) 艾日布林和乐伐替尼作为治疗癌症的联合疗法的用途
CN1917889A (zh) 镓在治疗炎性关节炎中的用途
CN102056609B (zh) 药物组合
Karthika et al. Can curcumin along with chemotherapeutic drug and lipid provide an effective treatment of metastatic colon cancer and alter multidrug resistance?
WO2021180111A1 (zh) 包括吡啶并[1,2-a]嘧啶酮化合物的药物组合
CA2929345A1 (en) Co-targeting androgen receptor splice variants and mtor signaling pathway for the treatment of castration-resistant prostate cancer
KR101563069B1 (ko) 다형 교모세포종의 치료를 위한 마시텐탄 포함 조합물
JP2016520665A (ja) Ｍｐｓ−１キナーゼ阻害剤および有糸分裂阻害剤を含む、癌の治療のための組合わせ
JP5241059B2 (ja) 腫瘍崩壊ウイルスを使用して疼痛を軽減するための方法
Yang et al. Local ablation of gastric cancer by reconstituted apolipoprotein B lipoparticles carrying epigenetic drugs
Macmillan et al. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck
ES2842431T3 (es) Composición para prevenir o tratar mucositis que comprende NecroX como ingrediente eficaz
TW202146016A (zh) 投予抗癌劑之方法
CN116473998A (zh) 一种氧化石墨烯自噬调节药物及其制备方法和应用
CN111065397A (zh) MEK/PI3K、JAK/MEK、JAK/PI3K/mTOR和MEK/PI3K/mTOR生物学途径的抑制剂和用于改善治疗化合物的淋巴摄取、生物利用度和溶解度的方法
CN107308121A (zh) 肝脏再生的治疗剂
CN103599108A (zh) 齐墩果酸在制备预防和治疗胆汁淤积症药物中的应用
WO2025188928A1 (en) Administration of low-dose thiostrepton for treating cancer
TWI620566B (zh) 三萜混合物用以治療多發性硬化的用途
Garcia et al. Enteral Activation of WR-2721 Mediates Radioprotection and Improved survival from Lethal Fractionated Radiation
CN106692160A (zh) 肝再生的治疗剂
WO2014098552A1 (es) Composición farmacéutica que comprende la combinación de un agente antiinflamatorio no esteroideo, un agente adyuvante y un analgésico antineurítico, con efecto antinociceptivo

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201030